Spacelabs Healthcare launches Ultraview vital signs monitor

4 May 2010

Spacelabs Healthcare has launched the Ultraview DM3 dual-mode vital signs monitor for adult and paediatric patients. It monitors SpO2, pulse rate, non-invasive blood pressure, respiration and temperature.

The latest in the Ultraview series, the new DM3 can be used in any patient care environment where basic vital signs monitoring is needed. In Spot-Check mode, the DM3 supports batch collection of basic vitals for multiple patients.

Supplemental patient information, such as pain level, patient position (during NIBP), site check, and caregiver ID, can also be specified by the user for inclusion in the patient’s record. After collection of patient vitals has been completed, the DM3 can be connected to the network to transmit the spot-check records for one or multiple patients to the hospital’s EMR system.

In Monitoring mode, the DM3 provides continuous monitoring and alarm support for patients who require more vigilance. In those instances, such as following a procedure, short-term but constant monitoring may be necessary based on variable patient acuity.

“In keeping with Spacelabs’ tradition of connecting innovation with care, we are pleased to introduce the Ultraview DM3, a versatile and cost-effective clinical solution, as well as an exciting addition to our expanding line of monitoring and diagnostic products,” said Group President Nicholas Ong.

The Ultraview DM3 has just recently received FDA 510(k) clearance for market and sale within the United States. Plans are underway to expand marketing and sales efforts into Canada, Europe, Middle East and Africa.

To top